This Fourth of July, we celebrate 250 years of bold ideas, determination and the pursuit of a brighter future.
From all of us at Exxel Pharma, Happy Independence Day and best wishes for a safe and memorable holiday.
#IndependenceDay
#WhoWeAre
At Exxel Pharma, we are focused on advancing science-driven therapies designed to target the underlying mechanisms of neuronal hypersensitivity disorders and improve the lives of patients impacted by chronic neurological conditions.
#ChronicCough#HyperactiveBladder
Stay connected with the latest updates from Exxel. Sign up for email alerts and receive company news directly to your inbox.
https://t.co/yzdyETz3c8
#ChronicCough#HyperactiveBladder
We are advancing innovative therapeutic approaches across multiple high-value indications where patients continue to need better solutions.
#ChronicCough#HyperactiveBladder
For those living with refractory #ChronicCough, the impact goes far beyond the symptom itself.
With limited treatment options available today, there remains a clear need for new approaches.
Want to stay informed on our latest developments?
Sign up to receive updates on our research, pipeline and company news:
https://t.co/yzdyETz3c8
#NeuropathicPain#ChronicCough
We are advancing innovative therapies across high-value indications, unlocking new possibilities where meaningful breakthroughs are needed most.
#ChronicCough#NeuropathicPain
#DidYouKnow chronic cough still has no FDA-approved treatments, leaving many patients with limited options.
At Exxel Pharma, we’re committed to advancing research and pursuing innovative solutions to help close this gap.
#ChronicCough#NeuropathicPain
Millions of patients with #ChronicCough still face daily disruption with few effective treatment options.
Exxel Pharma is committed to advancing science to close these gaps and deliver meaningful improvements for patients.
At Exxel Pharma, patients are at the center of everything we do.
We are dedicated to advancing our research with integrity, accountability and a focus on a lasting impact.
#ChronicCough#NeuropathicPain
#DidYouKnow?
With #ChronicCough, hypersensitive sensory neurons overreact to everyday triggers like temperature changes, scents or even talking, causing a disruptive cough reflex.
At Exxel Pharma, we recognize this is more than just a cough.
#DidYouKnow: Chronic cough is a persistent and distressing cough lasting longer than 8 weeks in adults. Learn more: https://t.co/IgIdnjsjno
#ChronicCough#NeuropathicPain
#WhoWeAre
Exxel Pharma is a privately held pharmaceutical company dedicated to developing novel therapies for patients living with neuronal hypersensitivity disorders.
#ChronicCough#NeuropathicPain
#ChronicCough is a persistent, disruptive cough lasting longer than 8 weeks in adults. It can significantly reduce quality of life, impacting daily activities, sleep and social interactions.
Exxel Pharma is working to bring new treatment options to those affected.
At Exxel Pharma, we are advancing breakthrough therapeutics designed to transform the treatment of neuronal hypersensitivity disorders.
Our goal is to bring innovative, science-driven solutions to patients who need them most.
#ChronicCough#NeuropathicPain
Want to learn more about Exxel Pharma? Explore our publications for in-depth insights and groundbreaking advancements.
https://t.co/BsUtpRMCKP
#ChronicCough#Migraine#NeuropathicPain